Definium Therapeutics Inc. shares rally as much as 60% Monday after late-stage trial data showed “groundbreaking” results in the psychedelic drug developer’s experimental treatment for major depressive disorders.

Source: [Bloomberg Markets](https://www.bloomberg.com/news/articles/2026-06-22/psychedelics-drug-developer-definium-surges-on-depression-trial-data)

Sponsored